{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:23:37Z","timestamp":1788499417330,"version":"build-2803163510"},"reference-count":28,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,19]]},"DOI":"10.31744\/einstein_journal\/2025ao1694","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:22:32Z","timestamp":1755696152000},"source":"Crossref","is-referenced-by-count":3,"title":["A new and useful tool for differentiating prolactinomas from non-functioning pituitary adenomas: a pilot study of the cabergoline disconnection test"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-6604","authenticated-orcid":false,"given":"Stefano Alvarenga","family":"Galliano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-0972","authenticated-orcid":false,"given":"Matheo Augusto Morandi","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1597-6616","authenticated-orcid":false,"given":"Nara L.","family":"Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Henrique Rodrigues","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1085-5689","authenticated-orcid":false,"given":"Flora Ladeira","family":"Craveiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0775-2711","authenticated-orcid":false,"given":"Christiane","family":"Gruetzmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2819-8281","authenticated-orcid":false,"given":"Gilberto Ochman da","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8005-5476","authenticated-orcid":false,"given":"Valter Angelo Sperling","family":"Cescato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1323-6488","authenticated-orcid":false,"given":"Eduardo Arnaldo Silva","family":"Vellutini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8263-374X","authenticated-orcid":false,"given":"Malebranche Berardo Carneiro","family":"Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-0301","authenticated-orcid":false,"given":"Rafael Loch","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8201-6756","authenticated-orcid":false,"given":"Andrea","family":"Glezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"12","key":"key20250820132227_B1","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BM, et al. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol. 2023;19(12):722-40.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"key20250820132227_B2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","article-title":"Prolactinomas","volume":"44","author":"Glezer","year":"2015","unstructured":"Glezer A, Bronstein MD. Prolactinomas. Endocrinol Metab Clin North Am. 2015;44(1):71-8.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"key20250820132227_B3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/BF03346388","article-title":"Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients","volume":"31","author":"Vilar","year":"2008","unstructured":"Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, et al. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest. 2008;31(5):436-44.","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"key20250820132227_B4","doi-asserted-by":"crossref","first-page":"E527","DOI":"10.1227\/NEU.0000000000001387","article-title":"Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas","volume":"79","author":"Fleseriu","year":"2016","unstructured":"Fleseriu M, Bodach ME, Tumialan LM, Bonert V, Oyesiku NM, Patil CG, et al. Congress of neurological surgeons systematic review and evidence-based guideline for pretreatment endocrine evaluation of patients with nonfunctioning pituitary adenomas. Neurosurgery. 2016;79(4):E527-9.","journal-title":"Neurosurgery"},{"issue":"10","key":"key20250820132227_B5","first-page":"18990","article-title":"The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas","volume":"8","author":"Zhang","year":"2015","unstructured":"Zhang F, Huang Y, Ding C, Huang G, Wang S. The prevalence of hyperprolactinemia in non-functioning pituitary macroadenomas. Int J Clin Exp Med. 2015;8(10):18990-7.","journal-title":"Int J Clin Exp Med"},{"issue":"2","key":"key20250820132227_B6","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s12020-024-03835-y","article-title":"Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery","volume":"85","author":"Sakata","year":"2024","unstructured":"Sakata K, Hashimoto A, Takeshige N, Orito K, Nagayama A, Ashida K, et al. Clinical and radiographic characteristics of patients with non-functioning pituitary adenomas categorized according to their serum prolactin concentration: novel predictors of postoperative transient diabetes insipidus following surgery. Endocrine. 2024;85(2):837-48.","journal-title":"Endocrine"},{"issue":"4","key":"key20250820132227_B7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","unstructured":"Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N, et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf). 2006;65(4):524-9.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20250820132227_B8","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/j.wneu.2021.12.074","article-title":"Serum prolactin level to tumor size ratio as a potential parameter for preoperative differentiation of prolactinomas from hyperprolactinemia-causing non-functional pituitary adenomas","volume":"159","author":"Kim","year":"2022","unstructured":"Kim JH, Hur KY, Hong SD, Choi JW, Seol HJ, Nam DH, et al. Serum prolactin level to tumor size ratio as a potential parameter for preoperative differentiation of prolactinomas from hyperprolactinemia-causing non-functional pituitary adenomas. World Neurosurg. 2022;159:e488-96.","journal-title":"World Neurosurg"},{"issue":"4","key":"key20250820132227_B9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11102-022-01246-8","article-title":"Prolactin immunoassay: does the high-dose hook effect still exist?","volume":"25","author":"Raverot","year":"2022","unstructured":"Raverot V, Perrin P, Chanson P, Jouanneau E, Brue T, Raverot G. Prolactin immunoassay: does the high-dose hook effect still exist? Pituitary. 2022; 25(4):653-7.","journal-title":"Pituitary"},{"key":"key20250820132227_B10","doi-asserted-by":"crossref","DOI":"10.20945\/2359-4292-2023-0502","article-title":"Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM)","volume":"68","author":"Glezer","year":"2024","unstructured":"Glezer A, Mendes Garmes H, Kasuki L, Martins M, Cond\u00e9 Lamparelli Elias P, Dos Santos Nunes Nogueira V, et al. Diagnosis of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the Brazilian Society of Endocrinology and Metabolism (SBEM). Arch Endocrinol Metab. 2024;68:e230502.","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"key20250820132227_B11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00004728-199207000-00004","article-title":"Volume of pituitary macroadenomas: assessment by MRI","volume":"16","author":"Lundin","year":"1992","unstructured":"Lundin P, Pedersen F. Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr. 1992;16(4):519-28.","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"key20250820132227_B12","first-page":"841","article-title":"Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers","volume":"80","author":"Andreotti","year":"1995","unstructured":"Andreotti AC, Pianezzola E, Persiani S, Pacciarini MA, Strolin Benedetti M, Pontiroli AE. Pharmacokinetics, pharmacodynamics, and tolerability of cabergoline, a prolactin-lowering drug, after administration of increasing oral doses (0.5, 1.0, and 1.5 milligrams) in healthy male volunteers. J Clin Endocrinol Metab. 1995;80(3):841-5.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key20250820132227_B13","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/1756-0500-7-555","article-title":"Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging","volume":"7","author":"Kawaguchi","year":"2014","unstructured":"Kawaguchi T, Ogawa Y, Tominaga T. Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging. BMC Res Notes. 2014;7(1):555.","journal-title":"BMC Res Notes"},{"issue":"1","key":"key20250820132227_B14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9343(87)90373-1","article-title":"Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement","volume":"82","author":"Bevan","year":"1987","unstructured":"Bevan JS, Burke CW, Esiri MM, Adams CB. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med. 1987;82(1):29-32.","journal-title":"Am J Med"},{"issue":"1","key":"key20250820132227_B15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12020-009-9279-7","article-title":"Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma","volume":"37","author":"Hong","year":"2010","unstructured":"Hong JW, Lee MK, Kim SH, Lee EJ. Discrimination of prolactinoma from hyperprolactinemic non-functioning adenoma. Endocrine. 2010;37(1):140-7.","journal-title":"Endocrine"},{"issue":"4","key":"key20250820132227_B16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-21-0561","article-title":"Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline","volume":"185","author":"Biagetti","year":"2021","unstructured":"Biagetti B, Sarria-Estrada S, Ng-Wong YK, Martinez-Saez E, Caster\u00e0s A, Cordero Asanza E, et al. Shrinkage by the third month predicts long-term response of macroprolactinoma after cabergoline. Eur J Endocrinol. 2021;185(4):587-95.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key20250820132227_B17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/COC.0000000000000505","article-title":"Cabergoline in the management of residual nonfunctioning pituitary adenoma: a single-center, open-label, 2-year randomized clinical trial","volume":"42","author":"Batista","year":"2019","unstructured":"Batista RL, Musolino NR, Cescato VA, da Silva GO, Medeiros RS, Herkenhoff CG, et al. Cabergoline in the management of residual nonfunctioning pituitary adenoma: a single-center, open-label, 2-year randomized clinical trial. Am J Clin Oncol. 2019;42(2):221-7.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"key20250820132227_B18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11102-023-01365-w","article-title":"Cabergoline treatment for surgery-na\u00efve non-functioning pituitary macroadenomas","volume":"27","author":"Ayalon-Dangur","year":"2024","unstructured":"Ayalon-Dangur I, Turjeman A, Hirsch D, Robenshtok E, Tsvetov G, Gorshtein A, et al. Cabergoline treatment for surgery-na\u00efve non-functioning pituitary macroadenomas. Pituitary. 2024;27(1):52-60.","journal-title":"Pituitary"},{"issue":"1","key":"key20250820132227_B19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ecl.2007.10.011","article-title":"Nonfunctioning pituitary tumors and pituitary incidentalomas","volume":"37","author":"Molitch","year":"2008","unstructured":"Molitch ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008;37(1):151-71, xi.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"key20250820132227_B20","first-page":"834","article-title":"Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels","volume":"34","author":"Smith","year":"1994","unstructured":"Smith MV, Laws ER Jr. Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels. Neurosurgery. 1994;34(5):834-9.","journal-title":"Neurosurgery"},{"key":"key20250820132227_B21","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1016\/j.wneu.2023.03.085","article-title":"Intrasellar pressure is related to endocrine disturbances in patients with pituitary tumors","volume":"175","author":"Simander","year":"2023","unstructured":"Simander G, Dahlqvist P, Oja L, Eriksson PO, Lindvall P, Koskinen LD. Intrasellar pressure is related to endocrine disturbances in patients with pituitary tumors. World Neurosurg. 2023;175:e344-51.","journal-title":"World Neurosurg"},{"issue":"6","key":"key20250820132227_B22","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s10278-024-01153-3","article-title":"Identification of prolactinoma in pituitary neuroendocrine tumors using radiomics analysis based on multiparameter MRI","volume":"37","author":"Li","year":"2024","unstructured":"Li H, Liu Z, Li F, Xia Y, Zhang T, Shi F, et al. Identification of prolactinoma in pituitary neuroendocrine tumors using radiomics analysis based on multiparameter MRI. J Imaging Inform Med. 2024;37(6):2865-73.","journal-title":"J Imaging Inform Med"},{"issue":"1","key":"key20250820132227_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.17.00004","article-title":"Technical challenges in the clinical application of radiomics","volume":"1","author":"Shaikh","year":"2017","unstructured":"Shaikh FA, Kolowitz BJ, Awan O, Aerts HJ, von Reden A, Halabi S, et al. Technical challenges in the clinical application of radiomics. JCO Clin Cancer Inform. 2017;1(1):1-8.","journal-title":"JCO Clin Cancer Inform"},{"issue":"21","key":"key20250820132227_B24","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","unstructured":"van Griethuysen JJ, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104-7.","journal-title":"Cancer Res"},{"key":"key20250820132227_B25","doi-asserted-by":"crossref","first-page":"901385","DOI":"10.3389\/fendo.2022.901385","article-title":"Diagnostic criteria of small sellar lesions with hyperprolactinemia: prolactinoma or else","volume":"13","author":"Cho","year":"2022","unstructured":"Cho A, Vila G, Marik W, Klotz S, Wolfsberger S, Micko A. Diagnostic criteria of small sellar lesions with hyperprolactinemia: prolactinoma or else. Front Endocrinol (Lausanne). 2022;13:901385.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key20250820132227_B26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","article-title":"Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas","volume":"74","author":"Wright","year":"2021","unstructured":"Wright K, Lee M, Escobar N, Pacione D, Young M, Fatterpekar G, et al. Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas. Endocrine. 2021;74(1):138-45.","journal-title":"Endocrine"},{"issue":"2","key":"key20250820132227_B27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3171\/2019.3.JNS19121","article-title":"Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size","volume":"133","author":"Burke","year":"2019","unstructured":"Burke WT, Penn DL, Castlen JP, Donoho DA, Repetti CS, Iuliano S, et al. Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg. 2019;133(2):321-8.","journal-title":"J Neurosurg"},{"issue":"2","key":"key20250820132227_B28","first-page":"2010","article-title":"Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas","volume":"15","author":"Huang","year":"2018","unstructured":"Huang Y, Ding C, Zhang F, Xiao D, Zhao L, Wang S. Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas. Oncol Lett. 2018;15(2):2010-6.","journal-title":"Oncol Lett"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:22:36Z","timestamp":1755696156000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/a-new-and-useful-tool-for-differentiating-prolactinomas-from-non-functioning-pituitary-adenomas-a-pilot-study-of-the-cabergoline-disconnection-test\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":28,"alternative-id":["10.31744\/einstein_journal\/2025AO1694"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025ao1694","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eAO1694"}}